In an innovative approach to cancer care, Dr. Manish Agrawal, CEO and Co-founder of Sunstone Therapies, is pioneering the integration of psychedelic-assisted therapy (PAT) to treat not just the physical manifestations of cancer but also the mental and emotional toll it takes on patients. Drawing on over two decades of experience as an oncologist, Dr. Agrawal states that the impact of cancer extends beyond the physical to profoundly affect patients’ mental health, an area that has historically been overlooked in cancer treatment.
In our exclusive interview with Dr. Manish Agrawal , for ONCOLife , he delves into the transformative power of psychedelic-assisted therapy in cancer care. Addressing a crucial gap in traditional oncology, Dr. Agrawal discusses how this novel approach not only targets the physical tumor but also the pervasive mental and emotional turmoil cancer instills in patients and their families. Click the picture to view the PDF version : Pg 44-47.
The integration of Psychedelic Therapy in cancer care
Recent studies, including pivotal research from Johns Hopkins University and New York University in 2016, have illuminated the potential of psychedelics like psilocybin to alleviate depression and anxiety in cancer patients. These findings inspired Dr. Agrawal to transition from traditional oncology to focus on whole-person healing through Sunstone Therapies. This shift underscores a growing recognition of the need to treat the psychological repercussions of cancer, which can persist even after physical recovery.
A phase 2 clinical trial, published in JAMA Oncology and presented at the Annual Meeting of the American Society […]
The Role of Psychedelic-Assisted Therapy in Transforming Cancer Care
